The global rise in allergic diseases has made accurate identification of atopy increasingly important. The skin prick test is the most common diagnostic to
Objective: Bee stings, a prevalent issue globally, trigger severe allergic reactions and significantly impact physical health. However, their effects on psychologic well-being and quality of life, especially across seasons, are less understood. This study evaluates the impact of bee sting allergies on anxiety, somatization, and quality of life in children, with a focus on seasonal differences. Methods: Conducted at the Medical Faculty of Erciyes University, this prospective study involved 106 children aged 6–18 years—53 with bee sting allergies and 53 healthy controls. Assessments using the Screen for Child Anxiety-Related Disorders (SCARED), Children’s Somatization Inventory-24 (CSI-24), and Pediatric Quality of Life Inventory (PedsQL) were performed in winter and spring. Results: Children with bee sting allergies exhibited significantly higher anxiety and somatization compared to controls, with lower quality of life scores in physical, emotional, and academic domains. Seasonal variations showed increased anxiety in spring, with fluctuating somatization and quality of life indicators, although these changes were not statistically significant. Conclusion: Bee sting allergies significantly affect children’s anxiety, somatization, and quality of life, with seasonal changes exacerbating these impacts. Targeted interventions are needed to address these challenges, particularly during peak allergen periods.
Objective: Allergic rhinitis (AR) and allergic conjunctivitis (AC) are common atopic conditions of childhood that significantly impair sleep quality and health-related quality of life (HRQoL). Although effective treatment strategies exist, their broader impact on sleep and daily functioning has remained underexplored. This study aimed to evaluate the effect of AR and/or AC treatment on sleep quality and HRQoL in children using validated, parent-reported instruments. Methods: In this prospective observational cohort study, 98 children aged 6–13 years with AR and/or AC were treated according to standard guidelines. Sleep quality and HRQoL were assessed pre- and post-treatment using the Children’s Sleep Habits Questionnaire (CSHQ) and the Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ), respectively. Changes in scores were analyzed using the Wilcoxon Signed-Rank test. Results: Post-treatment evaluations demonstrated a significant reduction in total CSHQ scores (median: 56–43, P < 0.001), indicating improved sleep quality. Similarly, total PRQLQ scores decreased significantly (median: 3.47–2.28, P < 0.001), reflecting enhanced QoL. Improvements were observed in most subdomains, including nose and eye symptoms, activity limitations, and other symptoms. Conclusions: A 4-week standard treatment regimen for AR and/or AC led to significant improvements in sleep quality and HRQoL in children. These findings highlight the importance of early and appropriate management of allergic conditions to enhance both physical and functional well-being in pediatric patients.